HSBC/CALL/ABBOTT LABORATORIES/130/0.1/20.06.24 Stock

Warrant

DE000HG4AN30

Market Closed - Bid/Ask 15:35:38 2024-06-05 EDT After market 15:59:36
0.016 EUR 0.00% Intraday chart for HSBC/CALL/ABBOTT LABORATORIES/130/0.1/20.06.24 0.009 -43.75%
6 months-65.96%
Current year-80.49%
Date Price Change
24-06-05 0.016 0.00%
24-06-04 0.016 0.00%
24-06-03 0.016 0.00%
24-05-31 0.016 0.00%
24-05-30 0.016 0.00%

Real-time BOERSE MUENCHEN

Last update June 05, 2024 at 03:35 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer HSBC
WKN HG4AN3
ISINDE000HG4AN30
Date issued 2022-06-23
Strike 130 $
Maturity 2024-06-20 (15 Days)
Parity 10 : 1
Emission price 0.89
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.17
Lowest since issue 0.016
Spread 0.015
Spread %93.75%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.4 USD
Average target price
125.4 USD
Spread / Average Target
+21.22%
Consensus